These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 63428)

  • 1. [Liberation of plasminogen activators].
    Klöcking HP; Bock G; Drawert J; Hinsenbrock KP; Kaiser B; Sedlarik U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):404-24. PubMed ID: 63428
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the release of plasminogen activator.
    Markwardt F; Klöcking HP
    Thromb Res; 1976 Feb; 8(2):217-23. PubMed ID: 2993
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of adrenergic stimulation in the fibrinolytic activation induced by histamine shock.
    Dosne AM
    Pathol Biol (Paris); 1975 Dec; 23 suppl():63-5. PubMed ID: 772560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular markers of hemostatic mechanisms--interaction of plasminogen activator and its inhibitor].
    Sakata Y
    Rinsho Byori; 1989 Mar; 37(3):256-60. PubMed ID: 2787424
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Fibrin plate studies of plasminogen activator and inhibitor from pig leucocytes.
    Stegnar M; Kopitar M; Accetto B; Lebez D
    Thromb Diath Haemorrh; 1975 Sep; 34(1):339. PubMed ID: 810914
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluidity of cadaveric blood after sudden death: Part II. Mechanism of release of plasminogen activator from blood vessels.
    Takeichi S; Wakasugi C; Shikata I
    Am J Forensic Med Pathol; 1985 Mar; 6(1):25-9. PubMed ID: 4039106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activation and endotoxin.
    N Engl J Med; 1989 Sep; 321(13):903-4. PubMed ID: 2788817
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemostasiology. Antifibrinolytic mechanisms of the liver].
    Jedrychowski A; Parbhoo SP; Hillenbrand P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1139-42. PubMed ID: 417485
    [No Abstract]   [Full Text] [Related]  

  • 9. Vascular fibrinolytic activity in long term treatment with second generation sulfonylurea compounds.
    Almér LO
    Acta Endocrinol Suppl (Copenh); 1980; 239():53-5. PubMed ID: 6159764
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fibrinolysis and disseminated intravascular coagulation].
    Ikematsu S
    Rinsho Byori; 1985 Jun; Spec No 63():27-36. PubMed ID: 2931536
    [No Abstract]   [Full Text] [Related]  

  • 11. [Short-acting fibrinolysis in the etiology of venous thrombosis].
    Petäjä J; Myllylä G; Rasi V; Vahtera E
    Duodecim; 1988; 104(5):317-24. PubMed ID: 3139389
    [No Abstract]   [Full Text] [Related]  

  • 12. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
    Félez J; Rueda F
    Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthetic fibrinolytic agents.
    Davidson JF; Walker ID
    Prog Cardiovasc Dis; 1979; 21(5):375-96. PubMed ID: 154124
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenergic stimulation of regional plasminogen activator release in rabbits.
    Chandler WL; Loo SC; Mornin D
    Thromb Haemost; 1992 Nov; 68(5):545-9. PubMed ID: 1455402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism of fibrinolysis.
    Lijnen HR; Collen D
    Adv Exp Med Biol; 1984; 164():217-28. PubMed ID: 6421102
    [No Abstract]   [Full Text] [Related]  

  • 16. Immobilization of the plasminogen activator streptokinase and its fibrinolytic effects in vivo.
    Mercer LC; Everse KE; Holmes AW; Everse J
    Thromb Res; 1978 Dec; 13(6):931-40. PubMed ID: 107613
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current developments in fibrinolytic therapy].
    Rijken DC
    Ned Tijdschr Geneeskd; 1985 Sep; 129(37):1768-72. PubMed ID: 3934567
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum-dependent induction of plasminogen activator in human fibroblasts by catecholamines and comparison with the effects of prostaglandin E1.
    Conanan LB; Crutchley DJ
    Biochim Biophys Acta; 1983 Sep; 759(3):146-53. PubMed ID: 6683974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of caffein ingestion on plasma fibrinolytic potential.
    Wojta J; Kirchheimer JC; Peska MG; Binder BR
    Thromb Haemost; 1988 Apr; 59(2):337-8. PubMed ID: 3133816
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol.
    Verheijen JH; Rijken DC; Chang GT; Preston FE; Kluft C
    Thromb Haemost; 1984 Jul; 51(3):396-7. PubMed ID: 6437007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.